If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
37.30    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.26 (3.356%)
Market Cap: £377.73m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Directorate Change

1 Nov 2022 07:00

RNS Number : 8197E
Aston Martin Lagonda Glob.Hldgs PLC
01 November 2022
 

1 November 2022

Aston Martin Lagonda Global Holdings plc

Appointment of Non-executive Directors and Board Committee appointments

Aston Martin Lagonda Global Holdings plc (the "Company") announces the appointment of Ahmed Al-Subaey and Frederick Robertson to the Board as representative Non-executive Directors of the Public Investment Fund, with effect from 1 November 2022. The appointments are made in accordance with the Relationship Agreement entered into between the Company and the Public Investment Fund on 29 July 2022. 

Ahmed Al-Subaey is Chief Executive Officer of Bahri, the National Shipping Company of Saudi Arabia, which is listed on the Saudi Stock Exchange. Mr Al-Subaey holds a BSC and Masters degree in electrical engineering from the University of Arizona and an executive MBA from Stanford University. 

Frederick Robertson is Senior Director and Head of Public Investments, International Investments Division at the Public Investment Fund. Mr Robertson started his career as an investment analyst having studied economics at Cornell University. Mr Robertson will be appointed as a member of the Nomination Committee and an observer to both the Audit and Risk Committee and Remuneration Committee with effect from 1 November 2022.

Lawrence Stroll, Executive Chairman of Aston Martin, said: "I am delighted to welcome Ahmed Al-Subaey and Frederick Robertson as PIF's appointed representatives to the Board. These appointments are an important part of our relationship with PIF, our second largest shareholder".

The Company confirms that there is no further information to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules of the Financial Conduct Authority with regard to either of these appointments.

The Company further announces the appointment of Sir Nigel Boardman as a member of the Nomination Committee and Audit and Risk Committee with effect from 1 November 2022. As previously announced, Sir Nigel was appointed as an independent Non-executive Director of the Company on 1 October 2022.

Enquiries

Investors and Analysts

Sherief Bakr

Director of Investor Relations

+44 (0)7789 177547sherief.bakr@astonmartin.com 

Holly Grainger

Deputy Head, Investor Relations

+44 (0)7442 989551holly.grainger@astonmartin.com 

Media

Kevin Watters

Director of Communications

+44 (0)7764 386683kevin.watters@astonmartin.com 

Paul Garbett

Head of Corporate and Brand Communications

 

+44 (0)7501 380799paul.garbett@astonmartin.com

Grace Barnie

Corporate Communications Manager

+44 (0)7880 903490grace.barnie@astonmartin.com 

Tulchan Communications

Harry Cameron and Simon Pilkington

+44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPGBCUUPPPUG
Date   Source Headline
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance
2nd Aug 20247:00 amRNSAnnouncement of successful private debt placing
24th Jul 20247:02 amRNSConfirmation of start date of new CEO
24th Jul 20247:00 amRNSHalf-year Report
10th Jun 20249:47 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSIssue of equity to satisfy employee share awards
8th May 202412:12 pmRNSAGM voting results
2nd May 20244:11 pmRNSDirector/PDMR Shareholding
1st May 20242:59 pmRNSESEF Annual Report 2023
1st May 20247:00 amRNSQ1 results for three months ended 31 March 2024
8th Apr 20249:00 amRNSAnnual Report 2023 and Notice of AGM
28th Mar 20244:10 pmRNSDirector Declaration
22nd Mar 20248:28 amRNSAppointment of New Chief Executive Officer
13th Mar 20246:16 pmRNSSuccessful pricing of £1.15 billion refinancing
12th Mar 20243:33 pmRNSHolding(s) in Company
11th Mar 20247:36 amRNSLaunch of Notes Offering
4th Mar 20249:05 amRNSIssue of equity to satisfy share awards
28th Feb 20247:00 amRNSPreliminary Results year ended 31 December 2023
20th Dec 20239:32 amRNSHolding(s) in Company
20th Dec 20239:31 amRNSHolding(s) in Company
8th Nov 20233:46 pmRNSHolding(s) in Company
8th Nov 20233:41 pmRNSHolding(s) in Company
8th Nov 20238:00 amRNSHolding(s) in Company
7th Nov 20233:23 pmRNSHolding(s) in Company
3rd Nov 202310:18 amRNSDirector/PDMR Shareholding
2nd Nov 20238:00 amRNSAdmission of shares and total voting rights
1st Nov 20237:00 amRNS3rd Quarter Results
30th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20232:14 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:13 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:10 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:07 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSIncreased investment by Yew Tree Consortium
19th Sep 202311:53 amRNSResult of Meeting
29th Aug 202312:01 pmRNSPublication of Circular and Notice of GM
4th Aug 20234:45 pmRNSHolding(s) in Company
4th Aug 20231:05 pmRNSDirector/PDMR Shareholding
4th Aug 202312:43 pmRNSDirector/PDMR Shareholding
4th Aug 202312:33 pmRNSDirector/PDMR Shareholding
4th Aug 202312:32 pmRNSDirector/PDMR Shareholding
4th Aug 202312:21 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSResult of Equity Issue
31st Jul 20234:41 pmRNSRetail Offer
31st Jul 20234:40 pmRNSProposed Share Placing
28th Jul 20237:00 amRNSAppointment of Non-executive Director
26th Jul 20232:49 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf-year Report
14th Jul 202312:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.